Neuroscience News

Wu Tsai Neuro affiliates Karl Deisseroth, Carolyn Rodriguez, Vivek Buch, Paul Nuyujukian, and team have created a super-charged, multidisciplinary in-patient research program and laboratory to better understand neuropsychiatric disorders.

A new technique using deep brain stimulation tailored to each patient exceeded researchers’ expectations in treating the cognitive impairments from moderate to severe traumatic brain injury.

This week, we dive into this misunderstood and often stigmatized world of epilepsy with Stanford neurologist Fiona Baumer.

It may not be smart, but we value something more if we’ve put a lot of sweat equity into it. Affiliates Neir Eshel and Rob Malenka, with support from the Wu Tsai Neuro–funded NeuroChoice Initiative, may have figured out the biochemical basis of why.

Wu Tsai Neuro affiliate Michelle Monje and other researchers find understanding the interplay between cancer tumors and the nervous system may be essential for winning the war on cancer.

This week, we talk with scientist and author David Eagleman about why some people's senses blend together and what it teaches us about how our perceptions shape our reality.

Stanford Medicine queried Wu Tsai Neuro and Knight Initiative affiliates share their expertise on the what the human brain are thinking about humans vs AI.

Wu Tsai Neuro affiliate Josef Parvizi unveils the surprising role of a small structure sandwiched between the brain’s two hemispheres.

This week, we talk about the neuroscience of sleep and how sleeplessness ages our bodies and our minds with Stanford psychiatry professor Luis de Lecea.

This week, we explore the collective intelligence of ant colonies with Deborah Gordon, a professor of biology at Stanford, an expert on ant behavior, and author of a new book, The Ecology of Collective Behavior.

When Anqi Zhang arrived at Stanford University as a postdoc, she had just spent six years learning to design and build brain implants: miniscule devices that could record the activity of neurons while causing minimal tissue damage.

Ketamine was no more effective than placebo in reducing depressive symptoms in surgical patients with major depression, results of a new study, which contradict prior research, suggest.

Erin Gibson’s lab has discovered that the precursor cells to myelin-producing oligodendrocytes are regulated by the circadian system in mice. When that regulation breaks down, the researchers saw abnormal myelination — but also fragmented sleep.

Working in the Gibson Lab, Brain Resilience Postdoc Scholar Daniela Rojo looks at how abnormal changes in gene activity impact the cells involved in producing myelin to the extent that it leads to neurodegeneration in the brain.

The Wu Tsai Neurosciences Institute is pleased to introduce our newest cohorts of Stanford Interdisciplinary Graduate Fellows (SIGFs).

This week, we explore the science of dizziness with Stanford Medicine neurologist Kristen Steenerson, MD, who treats patients experiencing vertigo and balance disorders.